Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0192 | 0.0589 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0192 | 0.0589 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0054 | 0.0085 | 0.0085 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0054 | 0.0085 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0312 | 0.1029 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0281 | 0.0914 | 0.8855 |
Brugia malayi | Serotonin receptor | 0.0512 | 0.1761 | 0.1761 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0464 | 0.1588 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0043 | 0.0041 | 0.5 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0043 | 0.0041 | 0.1442 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0044 | 0.0048 | 0.0031 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0054 | 0.0085 | 0.091 |
Schistosoma mansoni | hypothetical protein | 0.0078 | 0.017 | 0.0153 |
Echinococcus granulosus | tumor protein p63 | 0.2175 | 0.786 | 0.7857 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0054 | 0.0085 | 0.0279 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0464 | 0.1588 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0312 | 0.1029 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0114 | 0.0302 | 0.0302 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0044 | 0.0048 | 0.1556 |
Mycobacterium tuberculosis | Conserved protein | 0.0053 | 0.0081 | 0.055 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0044 | 0.0048 | 0.021 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0054 | 0.0085 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0034 | 0.0017 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0464 | 0.1588 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0054 | 0.0085 | 0.0279 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0281 | 0.0914 | 0.8855 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0124 | 0.034 | 0.0324 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0034 | 0.0017 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0192 | 0.0589 | 0.0573 |
Entamoeba histolytica | hypothetical protein | 0.0192 | 0.0589 | 1 |
Brugia malayi | hypothetical protein | 0.0192 | 0.0589 | 0.0589 |
Schistosoma mansoni | hypothetical protein | 0.0146 | 0.042 | 0.0404 |
Brugia malayi | Thioredoxin reductase | 0.0123 | 0.0336 | 0.0336 |
Leishmania major | hypothetical protein, conserved | 0.0464 | 0.1588 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0034 | 0.0017 |
Trypanosoma cruzi | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.0053 | 0.0081 | 0.0257 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.2759 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0034 | 0.0017 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0054 | 0.0085 | 0.0584 |
Plasmodium falciparum | glutathione reductase | 0.0123 | 0.0336 | 1 |
Mycobacterium ulcerans | citrate (pro-3S)-lyase subunit beta | 0.0053 | 0.0081 | 0.9334 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0124 | 0.034 | 0.0324 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0043 | 0.0041 | 0.0025 |
Mycobacterium tuberculosis | Probable citrate (pro-3S)-lyase (beta subunit) CitE (citrase) (citratase) (citritase) (citridesmolase) (citrase aldolase) | 0.0053 | 0.0081 | 0.055 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0281 | 0.0914 | 0.8784 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0151 | 0.0438 | 0.0422 |
Echinococcus multilocularis | tumor protein p63 | 0.2175 | 0.786 | 0.7857 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0146 | 0.042 | 0.0404 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0054 | 0.0085 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0054 | 0.0085 | 0.0085 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0123 | 0.0336 | 0.3093 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0114 | 0.0302 | 0.0285 |
Echinococcus granulosus | citrate lyase subunit beta protein | 0.0053 | 0.0081 | 0.0064 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0036 | 0.0017 | 0.0017 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0192 | 0.0589 | 0.0573 |
Mycobacterium ulcerans | hypothetical protein | 0.0054 | 0.0085 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0043 | 0.0041 | 0.0025 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0043 | 0.0041 | 0.1442 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0044 | 0.0048 | 0.1556 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0054 | 0.0085 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0043 | 0.0041 | 0.0041 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0151 | 0.0438 | 0.0422 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0312 | 0.1029 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0054 | 0.0085 | 0.0279 |
Plasmodium falciparum | thioredoxin reductase | 0.0123 | 0.0336 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0085 | 0.0068 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0281 | 0.0914 | 0.8855 |
Mycobacterium ulcerans | hypothetical protein | 0.0053 | 0.0081 | 0.9334 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0151 | 0.0438 | 0.0438 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0043 | 0.0041 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.224 | 0.8097 | 0.8094 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0054 | 0.0085 | 0.0584 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0054 | 0.0085 | 1 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0043 | 0.0041 | 0.0154 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0043 | 0.0041 | 0.0241 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0146 | 0.0422 | 0.0406 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0281 | 0.0914 | 0.8855 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0318 | 0.1052 | 0.1037 |
Schistosoma mansoni | microtubule-associated protein tau | 0.224 | 0.8097 | 0.8094 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0036 | 0.0017 | 0.0017 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0123 | 0.0336 | 0.1906 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0041 | 0.0034 | 0.0002 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.2759 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0034 | 0.0017 |
Echinococcus granulosus | microtubule associated protein 2 | 0.224 | 0.8097 | 0.8094 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0054 | 0.0085 | 0.091 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0043 | 0.0041 | 1 |
Leishmania major | trypanothione reductase | 0.0123 | 0.0336 | 0.1906 |
Brugia malayi | glutathione reductase | 0.0123 | 0.0336 | 0.0336 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0043 | 0.0041 | 0.0025 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0192 | 0.0589 | 0.0573 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0078 | 0.017 | 0.017 |
Leishmania major | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.0053 | 0.0081 | 0.0257 |
Trypanosoma cruzi | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.0053 | 0.0081 | 0.0257 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.0302 | 0.0285 |
Schistosoma mansoni | thyroid hormone receptor | 0.0158 | 0.0463 | 0.0447 |
Mycobacterium ulcerans | citrate lyase beta subunit, CitE_2 | 0.0053 | 0.0081 | 0.9334 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0123 | 0.0336 | 0.032 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0123 | 0.0336 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0043 | 0.0041 | 0.0243 |
Plasmodium vivax | glutathione reductase, putative | 0.0123 | 0.0336 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0054 | 0.0085 | 0.091 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.2759 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0114 | 0.0302 | 0.0302 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0085 | 0.0068 |
Mycobacterium tuberculosis | Probable reductase | 0.0281 | 0.0914 | 0.8855 |
Plasmodium falciparum | glutathione reductase | 0.0043 | 0.0041 | 0.0243 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0054 | 0.0085 | 1 |
Treponema pallidum | NADH oxidase | 0.0043 | 0.0041 | 0.5 |
Onchocerca volvulus | 0.0318 | 0.1052 | 1 | |
Loa Loa (eye worm) | glutathione reductase | 0.0123 | 0.0336 | 0.032 |
Toxoplasma gondii | thioredoxin reductase | 0.0123 | 0.0336 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0192 | 0.0589 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0123 | 0.0336 | 0.1906 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.017 | 0.0153 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2759 | 1 | 1 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0043 | 0.0041 | 0.0241 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0043 | 0.0041 | 0.5 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0044 | 0.0048 | 0.0446 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0312 | 0.1029 | 1 |
Trichomonas vaginalis | Citrate lyase beta chain, putative | 0.0053 | 0.0081 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0158 | 0.0463 | 0.0447 |
Mycobacterium ulcerans | citrate (pro-3S)-lyase subunit beta | 0.0053 | 0.0081 | 0.9334 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0146 | 0.042 | 0.0404 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0043 | 0.0041 | 0.1442 |
Mycobacterium ulcerans | hypothetical protein | 0.0053 | 0.0081 | 0.9334 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0041 | 0.0034 | 0.0081 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0158 | 0.0463 | 0.0447 |
Schistosoma mansoni | hypothetical protein | 0.0192 | 0.0589 | 0.0573 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0043 | 0.0041 | 0.0243 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.1052 | 0.1037 |
Brugia malayi | AMP-binding enzyme family protein | 0.0054 | 0.0085 | 0.0085 |
Loa Loa (eye worm) | acetyltransferase | 0.0151 | 0.0438 | 0.0422 |
Echinococcus multilocularis | citrate lyase subunit beta protein | 0.0053 | 0.0081 | 0.0064 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0054 | 0.0085 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0043 | 0.0041 | 0.0243 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0044 | 0.0048 | 0.021 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0281 | 0.0914 | 0.8855 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0085 | 0.0068 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Delta MST (functional) | = 2.2 day | Antitrypanosomal activity was evaluated against Trypanosoma rhodesiense infections in mice,at dose 1.6mg/kg,administered subcutaneously | ChEMBL. | 4067999 |
Delta MST (functional) | = 3 day | Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 13 mg/kg administered subcutaneously | ChEMBL. | 4067999 |
Delta MST (functional) | = 3.2 day | Antitrypanosomal activity was evaluated against Trypanosoma rhodesiense infections in mice,at dose 212 mg/kg,administered subcutaneously | ChEMBL. | 4067999 |
Delta MST (functional) | = 4.9 day | Antitrypanosomal activity was evaluated against Trypanosoma rhodesiense infections in mice,at dose 53 mg/kg,administered subcutaneously | ChEMBL. | 4067999 |
Delta MST (functional) | = 7.2 day | Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 3.3 mg/kg administered subcutaneously | ChEMBL. | 4067999 |
Delta MST (functional) | = 8.9 day | Anti-trypanosomal activity against Trypanosoma rhodesiense infections in mice, 26 mg/kg administered subcutaneously | ChEMBL. | 4067999 |
Delta MST (functional) | = 11.2 day | Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 106 mg/kg administered subcutaneously | ChEMBL. | 4067999 |
Delta MST (functional) | = 13.5 day | Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 6.6 mg/kg administered subcutaneously | ChEMBL. | 4067999 |
Toxic (functional) | = 5 | Antitrypanosomal activity against Trypanosoma rhodesiense infections in mice, 424 mg/kg administered subcutaneously | ChEMBL. | 4067999 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.